GlassScriptPhysician profile
Deirdre M Marshall
NPI 1508880733
$14,021.97
in general payments reported to CMS, 2019-2025
21 companies · $743 in 2025
The $743 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,074 · 2020: $3,361 · 2021: $1,118 · 2022: $1,044 · 2023: $3,534 · 2024: $1,148 · 2025: $743.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,823 · Travel and Lodging: $1,602.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,823.26 |
| Travel and Lodging | $1,601.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,954.48 | 2023-2025 | |
| Musculoskeletal Transplant Foundation INC. | $2,872.22 | 2020-2025 | |
| Mentor Worldwide LLC | $2,398.84 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $1,702.39 | 2019-2022 | |
| Merz North America, INC. | $1,429.67 | 2019-2021 | |
| Tela Bio, INC. | $885.94 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Axogen | $392.26 | 2019-2023 | Avance Nerve Graft |
| Checkpoint Surgical, INC | $236.09 | 2020-2022 | |
| Sientra, INC. | $166.62 | 2019-2022 | |
| Biotissue Holdings INC. | $164.05 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $158.66 | 2019-2022 | |
| Amniox Medical, INC. | $119.02 | 2019 | |
| Integra Lifesciences Corporation | $114.74 | 2019 | |
| Organogenesis INC. | $99.99 | 2020 | |
| Acell, INC. | $94.54 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biopro, INC. | $66.67 | 2019 | |
| Apyx Medical Corporation | $55.35 | 2020 | |
| Davol INC. | $44.27 | 2020 | |
| Dilon Technologies, INC. | $24.10 | 2023 | Hemoblast Bellows |
| Mimedx Group, INC. | $23.26 | 2024 | |
| Avanos Medical | $18.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deirdre Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.